Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(50%)
Terminated
1(25%)

Phase Distribution

Ph phase_1
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Terminated(1)
Other(1)

Detailed Status

Recruiting2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (100.0%)

Trials by Status

terminated125%
unknown125%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
unknownphase_1

Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer

NCT03807102
recruiting

The Role of B7-H4 in Tumor Vaccine

NCT06156150
recruiting

Tumor Vaccines for Solid Tumors

NCT06102837
terminatedphase_1

Derivation of Tumor Specific Hybridomas

NCT01702792

Clinical Trials (4)

Showing 4 of 4 trials
NCT03807102Phase 1

Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer

Unknown
NCT06156150

The Role of B7-H4 in Tumor Vaccine

Recruiting
NCT06102837

Tumor Vaccines for Solid Tumors

Recruiting
NCT01702792Phase 1

Derivation of Tumor Specific Hybridomas

Terminated

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4